GLP-1s: The Miracle Drug with Fine Print
US$ 26.88
glp 1 agonist history GLP-1 Receptor Market Size A schematic overview of GLP-1
Description
In the landmark study for semaglutide, participants were randomized to semaglutide or placebo plus lifestyle interventions
Obesity, currently defined as a body mass index (BMI) of 30 kg/m 2 or greater, affects 800 million people worldwide [1]
Current views on type 2 diabetes
As GLP-1 has been implicated as a mediator in the putative gutrenal axis (a rapid-acting feed-forward loop that regulates postprandial fluid and electrolyte homeostasis), direct actions on the kidney have been proposed
